Back to search

Article

Assessing disease modifying therapies in autosomal dominant polycystic kidney disease

2020-01-01

Abstract excerpt

Background: Vasopressin stimulates cyst growth in autosomal dominant polycystic kidney disease (ADPKD) and is a key therapeutic target. Evaluation of high water intake (HWI) as an alternative to pharmacological vasopressin blockade is supported by patients. However the feasibility, safety and adherence-promoting strategies required to deliver this were unknown. The aim of this thesis was to assess the feasibility...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2e0c7ce5-dab4-52f8-8e58-363d246addfe
DOI
10.17863/cam.63588
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Assessing disease modifying therapies in autosomal dominant polycystic kidney diseaseDOI 10.17863/cam.63588
Recent advances in autosomal-dominant polycystic kidney disease.Semantic proximity
New treatment paradigms for ADPKD: moving towards precision medicine.Semantic proximity
Use of the Urine-to-Plasma Urea Ratio to Predict ADPKD Progression.Semantic proximity
Renal aquaporins and water balance disorders.Semantic proximity
GLP-1 receptor agonists in ADPKD: from metabolic rationale to phenotype-enriched translational testing.Semantic proximity
Hydration, arginine vasopressin, and gluco-regulatory health in humans: A critical perspectiveSemantic proximity
Methodological issues in clinical trials of polycystic kidney disease: a focused review.Semantic proximity
Early renal abnormalities in autosomal dominant polycystic kidney disease.Semantic proximity
The vasopressin-aquaporin-2 pathway syndromes.Semantic proximity
Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease.Semantic proximity
Data Driven Approach to Characterize Rapid Decline in Autosomal Dominant Polycystic Kidney DiseaseSemantic proximity
Everolimus in Patients with Autosomal Dominant Polycystic Kidney DiseaseSemantic proximity
Select a neighboring publication to make it the new centre.